| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
JW Shinyak Corporation (KQ: 067290)
067290 Technical Analysis
5
| As on 17th Dec 2025 067290 STOCK Price closed @ 2155.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1534.00 & Strong Buy for SHORT-TERM with Stoploss of 1529.31 we also expect STOCK to react on Following IMPORTANT LEVELS. |
067290STOCK Price
| Open | 1875.00 | Change | Price | % |
| High | 2365.00 | 1 Day | 263.00 | 13.90 |
| Low | 1696.00 | 1 Week | 649.00 | 43.09 |
| Close | 2155.00 | 1 Month | 765.00 | 55.04 |
| Volume | 45880705 | 1 Year | 660.00 | 44.15 |
| 52 Week High 2155.00 | 52 Week Low 1311.00 | ||||
KQ Korea Most Active Stocks
| 003310 | 2360.00 | 5.59% |
| 032980 | 302.00 | 16.15% |
| 067290 | 2155.00 | 13.90% |
| 365590 | 563.00 | 8.69% |
| 293580 | 1450.00 | 5.76% |
| 043220 | 171.00 | -29.63% |
| 000040 | 670.00 | 12.42% |
| 000040 | 670.00 | 12.42% |
| 330350 | 9550.00 | 9.27% |
| 214870 | 1383.00 | -27.44% |
KQ Korea Top Gainers Stocks
KQ Korea Top Losers Stocks
| 067290 Daily Charts |
067290 Intraday Charts |
Whats New @ Bazaartrend |
067290 Free Analysis |
|
|
067290 Important Levels Intraday
| RESISTANCE | 3444.16 |
| RESISTANCE | 3030.72 |
| RESISTANCE | 2775.16 |
| RESISTANCE | 2519.61 |
| SUPPORT | 1790.40 |
| SUPPORT | 1534.84 |
| SUPPORT | 1279.28 |
| SUPPORT | 865.84 |
067290 Forecast December 2025
| 4th UP Forecast | 2615.55 |
| 3rd UP Forecast | 2467.85 |
| 2nd UP Forecast | 2376.55 |
| 1st UP Forecast | 2285.26 |
| 1st DOWN Forecast | 2024.75 |
| 2nd DOWN Forecast | 1933.45 |
| 3rd DOWN Forecast | 1842.15 |
| 4th DOWN Forecast | 1694.45 |
067290 Weekly Forecast
| 4th UP Forecast | 2673.36 |
| 3rd UP Forecast | 2507.12 |
| 2nd UP Forecast | 2404.36 |
| 1st UP Forecast | 2301.61 |
| 1st DOWN Forecast | 2008.40 |
| 2nd DOWN Forecast | 1905.64 |
| 3rd DOWN Forecast | 1802.88 |
| 4th DOWN Forecast | 1636.64 |
067290 Forecast2025
| 4th UP Forecast | 4243.87 |
| 3rd UP Forecast | 3573.96 |
| 2nd UP Forecast | 3159.87 |
| 1st UP Forecast | 2745.78 |
| 1st DOWN Forecast | 1564.22 |
| 2nd DOWN Forecast | 1150.13 |
| 3rd DOWN Forecast | 736.04 |
| 4th DOWN Forecast | 66.13 |
JW Shinyak Corporation ( KQ Korea Symbol : 067290 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
067290 Business Profile
JW Shinyak Corporation, a pharmaceutical company, engages in the production and sale of medicines and medical supplies in South Korea. The company offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. It also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells. The company was founded in 1981 and is based in Seoul, South Korea. Address: 2477, Nambusunhwan-ro, Seoul, South Korea, 137-864
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service